Security key
12674W109
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA)
CUSIP: 12674W109
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.00001 per share
- Shares outstanding
- 116,279,070
- Total 13F shares
- 72,777,604
- Share change
- +36,485,527
- Total reported value
- $110,698,611
- Put/Call ratio
- 22%
- Price per share
- $1.52
- Number of holders
- 85
- Value change
- +$55,724,802
- Number of buys
- 50
- Number of sells
- 58
Report period
Q2 2025
Institutions
85
Top holders
10
CABA full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Cabaletta Bio, Inc. SEC filings
Cabaletta Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 12674W109
Recent filing periods:
Top shareholders of CABA - Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bain Capital Life Sciences Opportunities III, LP |
13D/G
|
— |
10%
|
9,677,125
|
$15,483,400 | $0 | 30 Jun 2025 | |
| Adage Capital Management, L.P. |
13D/G
|
— |
10%
|
9,002,580
|
$14,404,128 | $0 | 30 Jun 2025 | |
| 5AM Ventures V, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
333,144
|
$6,771,685 | — | 01 Nov 2021 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
3.4%
|
3,970,026
|
$5,499,000 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13D/G
13F
|
The Vanguard Group · Company |
3.8%
|
3,450,727
|
$5,245,105 | $0 | 30 Jun 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
3.1%
|
3,634,473
|
$5,033,745 | — | 31 Mar 2025 | |
| Nichtberger Steven |
13D/G
|
— |
3.3%
|
3,034,499
|
$4,855,198 | $0 | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
1%
from 13D/G
|
3,452,147
|
$4,781,223 | — | 31 Mar 2025 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
2.4%
|
2,760,888
|
$3,823,830 | — | 31 Mar 2025 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
2.1%
|
2,433,728
|
$3,370,713 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.5%
|
1,708,888
|
$2,366,810 | — | 31 Mar 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
1.4%
|
1,662,401
|
$2,302,424 | — | 31 Mar 2025 | |
| CANTOR FITZGERALD, L. P. |
13F
|
Individual |
1.3%
|
1,484,585
|
$2,056,150 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.98%
|
1,141,297
|
$1,581,019 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.85%
|
984,095
|
$1,362,972 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.81%
|
938,718
|
$1,300,124 | — | 31 Mar 2025 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.73%
|
850,000
|
$1,177,250 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.59%
|
682,670
|
$942,000 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.42%
|
490,200
|
$678,927 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.42%
|
489,321
|
$678,000 | — | 31 Mar 2025 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.41%
|
477,210
|
$660,936 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.41%
|
471,500
|
$653,028 | — | 31 Mar 2025 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.39%
|
458,972
|
$635,676 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.37%
|
434,389
|
$601,630 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.34%
|
399,766
|
$553,676 | — | 31 Mar 2025 | |
| Almitas Capital LLC |
13F
|
Company |
0.32%
|
367,491
|
$508,975 | — | 31 Mar 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.3%
|
343,411
|
$475,624 | — | 31 Mar 2025 | |
| Raiffeisen Bank International AG |
13F
|
Company |
0.26%
|
300,000
|
$465,000 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.28%
|
330,541
|
$457,800 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.28%
|
321,411
|
$445,154 | — | 31 Mar 2025 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.25%
|
287,490
|
$398,172 | — | 31 Mar 2025 | |
| AXA S.A. |
13F
|
Company |
0.23%
|
270,077
|
$374,057 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.22%
|
251,437
|
$348,240 | — | 31 Mar 2025 | |
| Atle Fund Management AB |
13F
|
Company |
0.16%
|
182,354
|
$252,560 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.15%
|
168,899
|
$233,925 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.14%
|
159,866
|
$221,414 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
155,174
|
$214,915 | — | 31 Mar 2025 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
0.08%
|
95,327
|
$132,000 | — | 31 Mar 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.08%
|
88,600
|
$122,711 | — | 31 Mar 2025 | |
| TCG Crossover Management, LLC |
13F
|
Company |
0.07%
|
86,795
|
$120,211 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.06%
|
73,956
|
$102,429 | — | 31 Mar 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.06%
|
64,630
|
$89,513 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.05%
|
61,675
|
$85,420 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.05%
|
61,405
|
$85,046 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.05%
|
61,388
|
$85,014 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.05%
|
57,780
|
$80,025 | — | 31 Mar 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.05%
|
57,036
|
$78,995 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.05%
|
56,438
|
$78,167 | — | 31 Mar 2025 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.04%
|
49,554
|
$68,633 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
45,675
|
$63,260 | — | 31 Mar 2025 |
Institutional Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q2 2025
As of 30 Jun 2025,
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) was held by
85 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
72,777,604 shares.
The largest 10 holders included
Bain Capital Life Sciences Investors, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., T. Rowe Price Investment Management, Inc., JENNISON ASSOCIATES LLC, Cormorant Asset Management, LP, Alyeska Investment Group, L.P., VANGUARD GROUP INC, HEIGHTS CAPITAL MANAGEMENT, INC, PRICE T ROWE ASSOCIATES INC /MD/, and Jefferies Financial Group Inc..
This page lists
84
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
91
Q2 2025 holders
85
Holder diff
-6
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.